Injective Surges on Institutional Validators and Enterprise Developments

Injective (INJ) has seen a surge in value over the last ~34 hours, driven by fresh institutional validator news and ongoing enterprise developments. The price increase of around 3-4% is attributed to several factors, including Bitwise's launch of a validator node on the Injective network, as well as the participation of another institution, Four Pillars FP.

Bitwise's move is seen as a vote of confidence in Injective's DeFi/RWA infrastructure, allowing large holders to stake through a brand they already trust. This narrative has attracted both new buyers and stakers, contributing to the price increase.

In addition to institutional validator news, enterprise developments such as the POSCO/LG CNS trade finance pilot and mainnet upgrades have also contributed to the surge in value. The upcoming August community buyback is also expected to support a deflationary narrative.